BIO.News Newsletter

ICYMI: The PASTEUR Act was reintroduced in the Senate. Plus, more from BIO 2026, including the latest on the 340B program and what the media was covering at the Convention. (639 words, 3 minutes, 12 seconds)

As BIO 2026 comes to a close, we look ahead to biotech's sixth decade. Pioneering patients remind us why innovation matters, and experts outline what will shape biotech's next decade, and leaders warn that protecting intellectual property remains essential to American biotech leadership. (882 words, 4 minutes, 25 seconds)

Day 3 of BIO 2026 looked ahead to biotech's next chapter: how AI could accelerate drug discovery, why U.S. biotechnology leadership is a national security priority, and what states can do to compete for the industry's next generation of growth. (670 words, 3 minutes, 14 seconds)

On Tuesday, BIO 2026 attendees explored what it will take to maintain America's innovation edge, while a new industry report offered fresh evidence that capital is returning to the sector and emerging biotechs remain the industry's innovation engine. Plus, leadership advice from Gary Sinise and Marcus Freeman. (675 words, 3 minutes, 15 seconds)

Patient groups happy Virginia won't have a PDAB. Plus, seeking clarity about onshoring agreements. (789 words, 3 minutes, 10 seconds)

Hearings on data protection and IP have big significance for biotech. (884 words, 3 minutes, 33 seconds)

James Roe bringing his asthma story to BIO 2026. Plus Women's Health Month. (1,030 words, 3 minutes, 58 seconds)

How to make the most of partnering at BIO 2026. Plus our explainer on PDUFA. (719 words, 2 minutes, 53 seconds)

BIO's Ohio trip spotlights gene therapy hub. Plus biotech innovation in women's health. (854 words, 3 minutes, 25 seconds)

BIO launches Fight of Our Lives campaign. Plus, Kennedy visits the Hill. (799 words, 3 minutes, 12 seconds)